Results from the phase 4 COMPARE study indicate that Nuvaxovid exhibits a more favorable reactogenicity profile compared with the mNEXSPIKE mRNA vaccine.
It might seem surprising that, as a Japanese researcher, Eizo Takashima became captivated by malaria, when his home country rid itself of the disease in the last century. But, after a love of science ...
Discover how arbovirus E Dimer vaccines are engineered to improve safety by minimizing antibody dependent enhancement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results